Ashwath Jayagopal

Ashwath Jayagopal appears in our data through filings on Opus Genetics, Inc. shares, published by SEC (Form 4). Between 12 February 2024 and 23 April 2026, the trades on record add up to 8 filings.

On the open market, the record shows 1 purchase worth €5,707 and 2 sales worth €50k. The net balance comes to €44k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 share grants. 2026 to date brings no purchases and 2 sales.

The newest entry dates from 27 April 2026: an open-market sale of €34k, in Opus Genetics, Inc. The clock since the last published purchase (24 May 2024) now reads 877 days. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.